Lucky Man

Lucky Man

Patrick Soon-Shiong, the surgeon-turned-entrepreneur who invented the cancer drug Abraxane, established Lucky Man, LLC after the 2010 sale of his company Abraxis BioScience to Celgene. The deal injected roughly $2.9 billion in cash and stock into his personal balance sheet, creating the capital base the office deploys today. The name references Soon-Shiong's self-described identity, derived from a nickname given by a patient's family early in his career. Lucky Man's deployment reflects Soon-Shiong's conviction that media, technology, and biology will converge. The office owns the Los Angeles Times and the San Diego Union-Tribune, acquired in 2018 and 2015 respectively, and has directed investment into biotechnology through NantWorks, an ecosystem of companies including NantHealth and ImmunityBio. Real estate holdings include significant commercial and residential property in the Los Angeles area. The investment posture is intensely personal — no external limited partners, no fund cycles, and capital allocated directly from Soon-Shiong's own treasury. The office operates with minimal public disclosure regarding headcount or total deployment figures. It runs from Los Angeles, where Soon-Shiong maintains his primary residence and business operations. The approach combines elements of an operating business, a venture studio, and a traditional family office, with decisions flowing through Soon-Shiong personally. No external fundraising or co-investment clubs have been disclosed. What separates Lucky Man from single-family offices of comparable scale is the deliberate entanglement of the principal's civic ambitions, scientific convictions, and investment capital. The purchase of a major metropolitan newspaper alongside the continued funding of clinical-stage biotech creates a balance sheet with no obvious peer — patient capital deployed at the intersection of public influence, scientific discovery, and long-duration asset ownership. Succession remains undisclosed, with Soon-Shiong's adult children holding no named operating roles in the office.